メニュー

Tissue Engineering and Regenerative Medicine

作者: QuNaMai リリース時間: 2025-09-14 18:33:37 ビュー番号: 823

Structured Analysis of QuNaMai Medical Technology Cooperation Program (Focus on Strategic Positioning and Partner Opportunities)

I. QuNaMai's Core Value Proposition

As a R&D-driven enterprise with no production assets, QuNaMai focuses 100% on high-barrier medical technology fields. Its core business directions include:

 

  • Tissue Engineering (allogeneic natural killer cells, regenerative scaffolds)
  • Medical Aesthetic Technology (R&D of microsphere injectables)
  • High-end Preparations (medical-grade skincare products / functional foods)
  • Emergency Medical Shelters (modular rapid deployment design)

II. Strategic Cooperation Models

(I) Overseas Investment Cooperation

  • Cooperation Logic: Leverage investors' resources to accelerate global market penetration.
  • Core Advantage: Increase market access speed by 30%-40% (e.g., obtaining FDA/CE certifications through partners' networks).
  • Target Planning:
    • Mid-term: Capture 15%-20% of the regional market share in the regenerative medicine / medical aesthetics sectors.
    • Long-term: Expand into emerging markets, achieving an output value of 2.2-2.7 billion yuan and an annual profit growth rate of 25%.

(II) Asset-Light Technology Output

Cooperation Model Responsibility Division Partner Benefits
Technology Licensing Provide complete technology packages + match with third-party factories No production risks
Joint Production QuNaMai (R&D) + Partner (localized production) Shared intellectual property control rights
Technology-Intermediated OEM Provide customized formulas + verified OEM supplier resources Access to over 30 certified factories

 

  • Core Commitment: QuNaMai assumes no production risks and only takes responsibility for ensuring technological stability and innovation.

III. Ideal Partner Profile

  • Mandatory Requirement: Possess compliance certification capabilities in target markets (e.g., FDA, CE).
  • Key Cooperation Targets:
    • Global medical technology investors seeking high-profit portfolios.
    • Cosmetics / health food brands in need of breakthrough formulas.
    • Medical OEM enterprises looking to upgrade their technology pipelines.

IV. Connecting with QuNaMai

  • View Technology Certifications: Visit the official website (www.tl-wc.com), which includes product demonstrations, market analyses, and technical specifications.
  • Direct Contact Methods:
    • Email: qunamai@163.com
    • Whatsapp: +86 15355436798
  • Service Commitment: Assign an exclusive technical / market consultant within 24 hours and provide customized cooperation plans.

V. Three Key Reasons to Choose QuNaMai

✅ Leadership in Niche Segments: Own 4 patent-protected technology systems in high-growth tracks.
✅ Low-Risk Scaling: The asset-light model ensures fast return on investment (ROI) with no capital expenditure (CAPEX) burden.
✅ Global Compliance Bridge: Shorten regulatory approval processes through partner synergy.

Next Step: Inform us of your target market / compliance resources → QuNaMai will customize a technology output or joint investment roadmap for you.

関連商品
関節鏡検査-関節鏡保護シース- 0°-30°-70°のマッチング
自己運営
関節鏡検査-関節鏡保護シース- 0°-30°-70°のマッチング
お願いします 値段を調べます
Sales:301
関節鏡検査
自己運営
関節鏡検査
お願いします 値段を調べます
Sales:982
脊髄内视镜-7.3MM-8.4MM-10.0MM
自己運営
脊髄内视镜-7.3MM-8.4MM-10.0MM
お願いします 値段を調べます
Sales:986
高品質尿管鏡大人子供尿管鏡です
自己運営
高品質尿管鏡大人子供尿管鏡です
お願いします 値段を調べます
Sales:686